Abstract Objective: To study the distribution and elimination of griseofulvin in rabbit tissues, and to provide the basis for safety assessment of griseofulvin used for the treatment of rabbit fungal dermatopathy. Methods: Fourty-two rabbits were fed with pellet feed containing 800g/1000kg griseofulvin for 14 days.The liver, kidney muscle, skin and brain of 6 rabbits were collected at different time point (withdrawal days 1, 3, 5, 7, 9, 12 and 21). The concentrations of griseofulvin in rabbit tissues were determined by LC-MS/MS method. Results: After continuous treatment, the griseofulvin concentration in liver tissue was the highest (134.61μg/kg), followed by kidney tissue (54.09μg/kg), the concentration of griseofulvin in brain tissue was the lowest (not detetable). After treatment, griseofulvin in muscle, liver, kidney and skin tissues were gradually eliminated. To withdrawal day 21, the griseofulvin concentrations in liver and kidney tissue were respectively 12.36μg/kg and 3.39μg/kg. The griseofulvin concentrations in other tissues were below the detection limit of quantification or not detectable. The elelimination rate of griseofulvin in the liver tissue was found to be the rapiddest. Conclusions: After continuous treatment, griseofulvin are distributed in the rabbit liver, kidney, muscle and skin tissues, and the concentration in liver tissue is the highest. To withdrawal day 21, griseofulvin residues in liver and kidney tissue still can be detected. The results suggest that griseofulvin should be used with caution. |